Sign In

Login

Password

Forgot Password ? Sign Up

Điều trị lao tiềm ẩn (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Điều trị lao tiềm ẩn" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
7nih.gov
4th place
7th place
3doi.org
2nd place
2nd place
1cdc.gov
218th place
163rd place
1clinicaltrials.gov
5,225th place
7,218th place
1ijmr.org.in
low place
low place
1archive.org
6th place
4th place

archive.org

cdc.gov

clinicaltrials.gov

  • Clinical trial number NCT01582711 for "Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT (iAdhere)" at ClinicalTrials.gov

doi.org

  • Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). “Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts”. Am J Respir Crit Care Med. 173 (8): 922–6. doi:10.1164/rccm.200512-1953OC. PMC 2662911. PMID 16474028.
  • Timothy R. Sterling; M. Elsa Villarino; Andrey S. Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E. Weis; Marc Weiner; Diane Wing; Marcus B. Conde; Lorna Bozeman; C. Robert Horsburgh, Jr.; Richard E. Chaisson (2011). “Three months of rifapentine and isoniazid for latent tuberculosis infection”. New England Journal of Medicine. 365: 2155–2166. doi:10.1056/NEJMoa1104875. PMID 22150035.
  • Flynn, J. L.; Chan, J. (2001). “Tuberculosis: Latency and Reactivation”. Infection and Immunity. 69 (7): 4195–201. doi:10.1128/IAI.69.7.4195-4201.2001. PMC 98451. PMID 11401954.

ijmr.org.in

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). “Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts”. Am J Respir Crit Care Med. 173 (8): 922–6. doi:10.1164/rccm.200512-1953OC. PMC 2662911. PMID 16474028.
  • Timothy R. Sterling; M. Elsa Villarino; Andrey S. Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E. Weis; Marc Weiner; Diane Wing; Marcus B. Conde; Lorna Bozeman; C. Robert Horsburgh, Jr.; Richard E. Chaisson (2011). “Three months of rifapentine and isoniazid for latent tuberculosis infection”. New England Journal of Medicine. 365: 2155–2166. doi:10.1056/NEJMoa1104875. PMID 22150035.
  • Menzies, Dick; Al Jahdali, Hamdan; Al Otaibi, Badriah (2011). “Recent developments in treatment of latent tuberculosis infection”. The Indian Journal of Medical Research. 133: 257–66. PMC 3103149. PMID 21441678.
  • Flynn, J. L.; Chan, J. (2001). “Tuberculosis: Latency and Reactivation”. Infection and Immunity. 69 (7): 4195–201. doi:10.1128/IAI.69.7.4195-4201.2001. PMC 98451. PMID 11401954.

ncbi.nlm.nih.gov

  • Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). “Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts”. Am J Respir Crit Care Med. 173 (8): 922–6. doi:10.1164/rccm.200512-1953OC. PMC 2662911. PMID 16474028.
  • Menzies, Dick; Al Jahdali, Hamdan; Al Otaibi, Badriah (2011). “Recent developments in treatment of latent tuberculosis infection”. The Indian Journal of Medical Research. 133: 257–66. PMC 3103149. PMID 21441678.
  • Flynn, J. L.; Chan, J. (2001). “Tuberculosis: Latency and Reactivation”. Infection and Immunity. 69 (7): 4195–201. doi:10.1128/IAI.69.7.4195-4201.2001. PMC 98451. PMID 11401954.